Barré, A.; Azzouz, R.; Gembus, V.; Papamicaël, C.; Levacher, V.
Design, Synthesis, and In Vitro Biological Activities of a Bio-Oxidizable Prodrug to Deliver Both ChEs and DYRK1A Inhibitors for AD Therapy. Molecules 2019, 24, 1264.
https://doi.org/10.3390/molecules24071264
AMA Style
Barré A, Azzouz R, Gembus V, Papamicaël C, Levacher V.
Design, Synthesis, and In Vitro Biological Activities of a Bio-Oxidizable Prodrug to Deliver Both ChEs and DYRK1A Inhibitors for AD Therapy. Molecules. 2019; 24(7):1264.
https://doi.org/10.3390/molecules24071264
Chicago/Turabian Style
Barré, Anaïs, Rabah Azzouz, Vincent Gembus, Cyril Papamicaël, and Vincent Levacher.
2019. "Design, Synthesis, and In Vitro Biological Activities of a Bio-Oxidizable Prodrug to Deliver Both ChEs and DYRK1A Inhibitors for AD Therapy" Molecules 24, no. 7: 1264.
https://doi.org/10.3390/molecules24071264
APA Style
Barré, A., Azzouz, R., Gembus, V., Papamicaël, C., & Levacher, V.
(2019). Design, Synthesis, and In Vitro Biological Activities of a Bio-Oxidizable Prodrug to Deliver Both ChEs and DYRK1A Inhibitors for AD Therapy. Molecules, 24(7), 1264.
https://doi.org/10.3390/molecules24071264